INSIGHTS ON DRUG DEVELOPMENT
-
Pairing Robust Analytical Methods With Efficient Process Development
Analytical Method Development is a critical phase in development, and its successful implementation is essential for delivering high-quality products to market efficiently and effectively.
-
Navigating The Analytical Complexity Of Oligonucleotide Therapeutics
From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.
-
Advances In Oral GLP-1 Analogs For Obesity
Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.
-
Mitigating Early Development Risks
Discover how the efficient screening of biologic candidates accelerates the discovery process, reduces costs, and improves the likelihood of commercializing safe and effective drugs.
-
Navigating Challenges During Formulation Development9/11/2024
Gain valuable knowledge on addressing formulation stability, improving product shelf life, and enhancing overall product performance in biopharmaceutical studies.
-
Formulation Considerations For The Development Of High Concentration Biopharmaceuticals9/11/2024
This session addresses key obstacles—such as opalescence, viscosity, and aggregation—and present real-world case studies on how composition changes during the concentration process can be effectively characterized.
-
Improving Therapeutic Protein Efficacy Through Charge Profile Adjustment9/10/2024
By adequately measuring charge variants early in development and implementing effective control strategies, developers can mitigate risks and ensure the safety and efficacy of their mAb products.
-
All You Need To Know About TCR Sequencing9/9/2024
Through detailed case studies and technical explanations, learn how TCR sequencing can improve patient stratification, treatment monitoring, and the development of novel therapeutics.
DRUG DEVELOPMENT SOLUTIONS
-
KBI’s extensive analytical capabilities help our clients develop lasting solutions to analytical challenges faced during the development of biologics.
-
Whether used for primary or secondary endpoints or in exploratory research, our seasoned scientists provide rigorous and scientifically robust support to ensure the successful application of biomarker assays.
-
The success of protein-based drugs hinges on identifying potential immune system reactions early in development. Learn about an immunogenicity testing technology that offers unparalleled sensitivity.
-
Taste, smell, and mouthfeel are the key product features to address when developing pediatric formulations. Incremental formulation and clinical research require cost-effective solutions with flexibility in manufacturing scale.
-
With services to develop and scale up Probiotics, Postbiotics and Microbial Therapeutics, explore how Sacco System’s capabilities can help take your drug product to market safely and efficiently.